MoneyWorks4Me

Concord Drugs - Quaterly Results

23 May 2025 Evaluate
The Sales for the quarter ended March 2025 of Rs. 79.69 million declined by -44.92% from Rs. 144.67 millions.The Total Profit for the quarter ended March 2025 of Rs. 0.08 millions grew from Rs.-3.53 millionsOperating profit surged to 9.31 millions from the corresponding previous quarter of 1.89 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 79.69 144.67 -44.92 369.46 432.70 -14.62 369.46 432.70 -14.62
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 9.31 1.89 392.59 37.77 36.87 2.44 37.77 36.87 2.44
Interest 5.35 3.77 41.91 17.18 15.90 8.05 17.18 15.90 8.05
PBDT 3.96 -1.88 -310.64 20.59 20.97 -1.81 20.59 20.97 -1.81
Depreciation 3.75 3.90 -3.85 14.18 15.38 -7.80 14.18 15.38 -7.80
PBT 0.21 -5.78 -103.63 6.41 5.59 14.67 6.41 5.59 14.67
TAX 0.13 -2.25 -105.78 3.46 1.39 148.92 3.46 1.39 148.92
Deferred Tax 0.19 -0.09 -311.11 1.56 -0.63 -347.62 1.56 -0.63 -347.62
PAT 0.08 -3.53 -102.27 2.95 4.20 -29.76 2.95 4.20 -29.76
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 11.68 1.31 794.27 10.22 8.52 19.98 10.22 8.52 19.98
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..